BLOUNT MEMORIAL HOSPITAL
1. Target Overview & Investment Thesis
BLOUNT MEMORIAL HOSPITAL is a 145-bed suburban community hospital in BLOUNT, TN with $326.0M in net patient revenue and a -8.5% operating margin. The hospital serves a payer mix of 22.3% Medicare, 1.8% Medicaid, and 75.9% commercial.
Thesis: Undervalued. Our ML models identify $24.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.5% to -1.2% (+736bps).
| Net Revenue HCRIS | $326.0M |
| Current EBITDA COMPUTED | $-27.8M |
| Operating Margin COMPUTED | -8.5% |
| Occupancy HCRIS | 67.0% |
| Revenue / Bed COMPUTED | $2.2M |
| Net-to-Gross HCRIS | 23.3% |
| Distress Probability ML | 41.3% |
2. Market Context & Competitive Position
TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -8.5% places it below the state median. Among 40 size-comparable peers (72-290 beds), the median margin is 3.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (72-290), prioritizing same-state peers. 40 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BLOUNT MEMORIAL HOSPITAL (Target) | TN | 145 | $326.0M | -8.5% |
| COOKEVILLE REGIONAL MEDICAL CE | TN | 212 | $372.5M | 2.1% |
| HOLSTON VALLEY HOSP & MED CTR | TN | 286 | $344.6M | -7.4% |
| MAURY REGIONAL HOSPITAL | TN | 244 | $334.0M | -9.7% |
| TENNOVA HEALTHCARE - TURKEY CR | TN | 219 | $326.2M | 8.1% |
| SUMMIT MEDICAL CENTER | TN | 188 | $298.0M | 40.6% |
| BRISTOL REGIONAL MEDICAL CENTE | TN | 244 | $293.9M | 3.2% |
| METRO NASHVILLE GENERAL HOSPIT | TN | 114 | $287.4M | 48.9% |
| WILLIAMSON HEALTH | TN | 203 | $271.4M | -3.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $24.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $6.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $6.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $209K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-27.8M |
| + RCM Uplift | +$24.0M |
| Pro Forma EBITDA | $-3.8M |
| Current Margin | -8.5% |
| Pro Forma Margin | -1.2% |
| WC Released (1x) | $12.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-42.7M | $56.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-42.7M | $48.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-38.4M | $114.0M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-38.4M | $113.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-47.0M | $-49.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-47.0M | $-69.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 40 hospitals with 72-290 beds
- Same-state prioritization (n=41)
- Comp margins: P25=-5.1% / P50=3.2% / P75=14.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.